The Neuroblastoma Post-HCT Data Form is one of the Comprehensive Report Forms. This form captures neuroblastoma (NEU) post-HCT data for the reporting period.

This form must be completed for all recipients whose primary disease, as reported on the Pre-TED Disease Classification (2402) Form, is Neuroblastoma (NEU) under Solid tumors. The Post-HCT Neuroblastoma (2126) Form must be completed in conjunction with each Post-HCT Follow-up (2100) Form. This form is designed to capture specific data occurring within the timeframe of each reporting period (i.e., between day 0 and day 100; between day 100 and the six-month date of contact for six-month follow-up; and between the date of contact for the six-month follow-up and the date of contact for the one-year follow-up, etc

Links to Sections of Form
Q1 – 159: Disease Assessments at Time of Best Response to HSCT

Manual Updates
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.

If you need to reference the historical Manual Change History for this form, please reference the retired manual section on the Retired Forms Manuals webpage.

Date Manual Section Add/ Remove/Modify Description
1/25/2021 2126: Neuroblastoma Post-Infusion Add Version 1 of the Neuroblastoma Post-Infusion section of the Forms Instructions Manual released. Version 1 corresponds to revision 2 of the Form 2126.
Last modified: Feb 01, 2021

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.